Correlation Between GM and Maat Pharma

Specify exactly 2 symbols:
Can any of the company-specific risk be diversified away by investing in both GM and Maat Pharma at the same time? Although using a correlation coefficient on its own may not help to predict future stock returns, this module helps to understand the diversifiable risk of combining GM and Maat Pharma into the same portfolio, which is an essential part of the fundamental portfolio management process.
By analyzing existing cross correlation between General Motors and Maat Pharma SA, you can compare the effects of market volatilities on GM and Maat Pharma and check how they will diversify away market risk if combined in the same portfolio for a given time horizon. You can also utilize pair trading strategies of matching a long position in GM with a short position of Maat Pharma. Check out your portfolio center. Please also check ongoing floating volatility patterns of GM and Maat Pharma.

Diversification Opportunities for GM and Maat Pharma

0.36
  Correlation Coefficient

Weak diversification

The 3 months correlation between GM and Maat is 0.36. Overlapping area represents the amount of risk that can be diversified away by holding General Motors and Maat Pharma SA in the same portfolio, assuming nothing else is changed. The correlation between historical prices or returns on Maat Pharma SA and GM is a relative statistical measure of the degree to which these equity instruments tend to move together. The correlation coefficient measures the extent to which returns on General Motors are associated (or correlated) with Maat Pharma. Values of the correlation coefficient range from -1 to +1, where. The correlation of zero (0) is possible when the price movement of Maat Pharma SA has no effect on the direction of GM i.e., GM and Maat Pharma go up and down completely randomly.

Pair Corralation between GM and Maat Pharma

Allowing for the 90-day total investment horizon General Motors is expected to generate 0.98 times more return on investment than Maat Pharma. However, General Motors is 1.02 times less risky than Maat Pharma. It trades about -0.09 of its potential returns per unit of risk. Maat Pharma SA is currently generating about -0.5 per unit of risk. If you would invest  5,004  in General Motors on November 29, 2024 and sell it today you would lose (158.00) from holding General Motors or give up 3.16% of portfolio value over 90 days.
Time Period3 Months [change]
DirectionMoves Together 
StrengthVery Weak
Accuracy91.3%
ValuesDaily Returns

General Motors  vs.  Maat Pharma SA

 Performance 
       Timeline  
General Motors 

Risk-Adjusted Performance

Very Weak

 
Weak
 
Strong
Over the last 90 days General Motors has generated negative risk-adjusted returns adding no value to investors with long positions. In spite of weak performance in the last few months, the Stock's primary indicators remain very healthy which may send shares a bit higher in March 2025. The recent disarray may also be a sign of long period up-swing for the firm investors.
Maat Pharma SA 

Risk-Adjusted Performance

Very Weak

 
Weak
 
Strong
Over the last 90 days Maat Pharma SA has generated negative risk-adjusted returns adding no value to investors with long positions. Despite weak performance in the last few months, the Stock's basic indicators remain somewhat strong which may send shares a bit higher in March 2025. The current disturbance may also be a sign of long term up-swing for the company investors.

GM and Maat Pharma Volatility Contrast

   Predicted Return Density   
       Returns  

Pair Trading with GM and Maat Pharma

The main advantage of trading using opposite GM and Maat Pharma positions is that it hedges away some unsystematic risk. Because of two separate transactions, even if GM position performs unexpectedly, Maat Pharma can make up some of the losses. Pair trading also minimizes risk from directional movements in the market. For example, if an entire industry or sector drops because of unexpected headlines, the short position in Maat Pharma will offset losses from the drop in Maat Pharma's long position.
The idea behind General Motors and Maat Pharma SA pairs trading is to make the combined position market-neutral, meaning the overall market's direction will not affect its win or loss (or potential downside or upside). This can be achieved by designing a pairs trade with two highly correlated stocks or equities that operate in a similar space or sector, making it possible to obtain profits through simple and relatively low-risk investment.
Check out your portfolio center.
Note that this page's information should be used as a complementary analysis to find the right mix of equity instruments to add to your existing portfolios or create a brand new portfolio. You can also try the Positions Ratings module to determine portfolio positions ratings based on digital equity recommendations. Macroaxis instant position ratings are based on combination of fundamental analysis and risk-adjusted market performance.

Other Complementary Tools

Portfolio Rebalancing
Analyze risk-adjusted returns against different time horizons to find asset-allocation targets
Pair Correlation
Compare performance and examine fundamental relationship between any two equity instruments
Bollinger Bands
Use Bollinger Bands indicator to analyze target price for a given investing horizon
Sync Your Broker
Sync your existing holdings, watchlists, positions or portfolios from thousands of online brokerage services, banks, investment account aggregators and robo-advisors.
Price Exposure Probability
Analyze equity upside and downside potential for a given time horizon across multiple markets